KBC Securities -

Report

KBC Securities

ASIT biotech: Pilot production unit established
Boskalis: Ostwind 2 â‚¬ 250m cable laying contract win
MDxHealth: Final US license for SelectMDx
Umicore: Lowering 2H forecasts

26/11/2018 8 EN

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Other Reports from KBC Securities

Guy Sips

Guy Sips

Materialise Medical segment continued to lead the way

We updated our Materialise model after 1Q24 revenues decreased 3% y/y as 1Q23 was an exceptionally strong quarter showing 24% growth. In 1Q24, Materialise's Medical segment continued to lead the way with 8% y/y revenue growth, while revenue declined in its Manufacturing and Software segments amidst less favourable market conditions. While continued investments in sustainable growth and the ongoing conversion to a recurring revenue business model impacted Materialise's operational profitability, they delivered a positive net result and an improved net cash position. We maintain our Buy rati...

14h / 21m 14h / 21m 1 EN

Wim Lewi

Wim Lewi

Xior 1Q24 Results show strong underlying performance, no JV deal

Xior 1Q24 EPRA EPS came far above our expectations at EUR 0.52 vs. 0.42 expected, thanks to a mix of factors: new assets + lfl growth, rental guarantees, cost savings and permitted hedging results. All these factors combined compensated the cost of debt increase to 3.18% (+88bps, bridge loan). The LTV came slightly below our expectation at 52.4% vs. 52.7% exp. The asset sale disposals advance with 100m closed and 220m committed, but Xior abandoned the route of a JV deal. The large asset sales like Naritaweg (A'dam) and the Zernike tower in Groningen are also no longer mentioned. FV impact of ...

16h / 57m 16h / 57m 1 EN

Sharad Kumar S.P

Sharad Kumar S.P

Quest for Growth Q1 FY24: Starting The Year With A €1.4m Net Loss

During 1Q24, Quest for Growth booked a net loss of –€1.4m while return on equity for the period was -1.0%. NAVps remained stable at €7.4ps (vs. €7.46ps during FY23-end). Within quoted assets, ABO Wind returned +42.0%, Tubize returned +25% and EVS Broadcasting returned +15% during 1Q24. Tubize and EVS are the largest positions in the portfolio as of 1Q24-end. On the other hand, LEM Holdings fell -18%, Melexis fell -18% and Equasens fell -16%; QfG added to their Equasens position during 1Q24. Harvia (saunas and sauna accessories) was a new addition to the listed portfolio and has returned +17.5...

17h / 3m 17h / 3m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

We are a financial services provider for several types of professional clients, each with distinct needs.

Materialise Medical segment continued to lead the way

Xior 1Q24 Results show strong underlying performance, no JV deal

Quest for Growth Q1 FY24: Starting The Year With A €1.4m Net Loss

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe